Simplex Trading’s Biocept, Inc. BIOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-130
Closed -$3K 10913
2022
Q3
$3K Sell
130
-493
-79% -$14.6K ﹤0.01% 9195
2022
Q2
$17K Sell
623
-267
-30% -$12.2K ﹤0.01% 7798
2022
Q1
$61K Buy
890
+820
+1,171% +$64.4K ﹤0.01% 6869
2021
Q4
$7K Sell
70
-257
-79% -$29.6K ﹤0.01% 9368
2021
Q3
$42K Hold
327
﹤0.01% 7745
2021
Q2
$41K Buy
327
+324
+10,800% +$43.9K ﹤0.01% 7907
2021
Q1
$47K Buy
3
+1
+50% +$182 ﹤0.01% 6707
2020
Q4
$25K Buy
+2
New +$285 ﹤0.01% 6839

Other funds holding BIOC

Simplex Trading's BIOC Position: Q2 2023 in Review

Simplex Trading sold out of Biocept, Inc. (BIOC) in Q2 2023, closing a stake of 16 shares.

Simplex Trading first reported a position in BIOC in Q1 2021 and held it in 6 quarters. The position peaked at $153K in Q1 2021. 11 funds tracked by Wall St. Rank hold BIOC as of Q2 2023.

  • Simplex Trading reported no remaining Biocept, Inc. position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 16 Biocept, Inc. shares in Q2 2023.
  • Simplex Trading first reported a position in Biocept, Inc. in Q1 2021 and held it in 6 quarters.
  • Simplex Trading's Biocept, Inc. position peaked at $153K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.